Oxford University study finds fully vaccinated Healthcare workers carry 251 times viral load compared to the unvaccinated proving the Covid-19 jabs make you worse

 

 

1x

-03:33

A groundbreaking preprint paper by the prestigious Oxford University Clinical Research Group, published Aug. 10 in The Lancet, includes alarming findings devastating to the COVID vaccine rollout. 

The study found vaccinated individuals carry 251 times the load of COVID-19 viruses in their nostrils compared to the unvaccinated.

By Dr Peter McCullough

While moderating the symptoms of infection, the jab allows vaccinated individuals to carry unusually high viral loads without becoming ill at first, potentially transforming them into presymptomatic superspreaders. 

This phenomenon may be the source of the shocking post-vaccination surges in heavily vaccinated populations globally. 

The paper’s authors, Chau et al, demonstrated widespread vaccine failure and transmission under tightly controlled circumstances in a hospital lockdown in Ho Chi Minh City, Viet Nam.

The scientists studied healthcare workers who were unable to leave the hospital for two weeks. The data showed that fully vaccinated workers — about two months after injection with the Oxford/AstraZeneca COVID-19 vaccine (AZD1222) — acquired, carried and presumably transmitted the Delta variant to their vaccinated colleagues. 

They almost certainly also passed the Delta infection to susceptible unvaccinated people, including their patients. Sequencing of strains confirmed the workers transmitted SARS-CoV-2 to one another. 

This is consistent with the observations in the U.S. from Farinholt and colleagues, and congruent with comments by the director of the Centers for Disease Control and Prevention conceding COVID-19 vaccines have failed to stop transmission of SARS-CoV-2.   

On Feb. 11, the World Health Organization indicated the AZD1222 vaccine efficacy of 63.09% against the development of symptomatic SARS-CoV-2 infection. The conclusions of the Chau paper support the warnings by leading medical experts that the partial, non-sterilizing immunity from the three notoriously “leaky” COVID-19 vaccines allow carriage of 251 times the viral load of SARS-CoV-2 as compared to samples from the pre-vaccination era in 2020. 

Thus, we have a key piece to the puzzle explaining why the Delta outbreak is so formidable — fully vaccinated are participating as COVID-19 patients and acting as powerful Typhoid Mary-style super-spreaders of the infection. 

Vaccinated individuals are blasting out concentrated viral explosions into their communities and fueling new COVID surges. Vaccinated healthcare workers are almost certainly infecting their coworkers and patients, causing horrendous collateral damage. 

Continued vaccination will only make this problem worse, particularly among frontline doctors and nurses workers who are caring for vulnerable patients. 

Health systems should drop vaccine mandates immediately, take stock of COVID-19 recovered workers who are robustly immune to Delta and consider the ramifications of their current vaccinated healthcare workers as potential threats to high risk patients and coworkers.

Abstract

Currently there are four major pharmaceutical companies who manufacture the Pfizer Vaccine, the Moderna Vaccine, the Astrazeneca Vaccine and the Janssen Vaccine for the purpose of providing immunity from the so-called infectious CoV - 2 virus now called the CoV - 19. These pharmaceutical companies have not provided FDA full-disclosure on the vaccine box, insert sheet or label for the major and minor ingredients contained within these vaccines. This research article now provides those specific major and minor ingredients contained in the Pfizer vaccine, the Moderna Vaccine, the Astrazeneca Vaccine and the Janssen Vaccine. As a human right, governed under World Law by the Nuremberg Code of 1947, the vaccine specific ingredient information is critical in determining by any human from any country in the World the ability to make an informed consent decision whether or not to receive the Corona virus inoculation.

There is a blackout on any conversation about how Ivermectin beat COVID-19 in India. When I discussed the dire straits that India found itself in early this year with 414,000 cases per day, and over 4,000 deaths per day, and how that evaporated within five weeks of the addition of Ivermectin, I am often asked, "But why is there no mention of that in the news?"

Yes, exactly. Ask yourself why India’s success against the Delta variant with Ivermectin is such a closely guarded secret by the NIH and CDC. Second, ask yourself why no major media outlets reported this fact, but instead, tried to confuse you with false information by saying the deaths in India are 10 times greater than official reports.

The U.S. Court of Appeals for the D.C. Circuit court ruled the Federal Communications Commission failed to provide a reasoned explanation for its determination that its current guidelines adequately protect against harmful effects of exposure to radiofrequency radiation.

NOTICE OF INTENDED PRIVATE CRIMINAL PROSECUTION MASS MURDER BY GOVERNMENT POLICY

https://www.thebernician.net/wp-content/uploads/2021/08/Notice-of-Intended-Criminal-Prosecution.pdf

If you examine DNA fragments that were obtained from humans or animals and incorrectly represented the basis of the hypothetical genetic strand of SARS-CoV-2, and you discover that the DNA has changed, the idea arises that SARS-CoV -2 would be mutated.

=> the idea of ​​the mutations of SARS-CoV-2 is based only on the interpretation of the fact that every DNA is constantly changing. Or, to put it more generally, the idea of ​​virus mutation only arises because one is still working with completely outdated, long-disproved scientific hypotheses.

In this way and with this outdated idea, new mutations of SARS-CoV-2 (er) can be found forever. This can quickly become a catastrophic surefire success and a vicious circle. And it looks like a lot of scientists have already gotten into this.

The origin of the (alleged) new coronavirus

 The Scientists’ Club. Download the full article here

This is an excellent summary made by the world Doctors alliance and the German extra Parliamentary Corono investigatio0n Committee. Click on the link below to read it

https://online.anyflip.com/inblw/ufbs/mobile/index.html?s=08&%3B

A total of 71 patients with Lyme disease were identified for analysis in whom treatment with disulfiram was initiated between 15 March 2017 and 15 March 2020. Four patients were lost to follow-up, leaving 67 evaluable patients. Our retrospective review found patients to fall into a “high-dose” group (≥4 mg/kg/day) and a “low-dose” group (<4 mg/kg/day). In total, 62 of 67 (92.5%) patients treated with disulfiram were able to endorse a net benefit of the treatment with regard to their symptoms. Moreover, 12 of 33 (36.4%) patients who completed one or two courses of “high-dose” therapy enjoyed an “enduring remission”, defined as remaining clinically well for ≥6 months without further anti-infective treatment. The most common adverse reactions from disulfiram treatment in the high-dose group were fatigue (66.7%), psychiatric symptoms (48.5%), peripheral neuropathy (27.3%), and mild to moderate elevation of liver enzymes (15.2%). We observed that although patients on high dose experienced a higher risk for adverse reactions than those on a low dose, high-dos patients were significantly more likely to achieve enduring remission.